TetraScience has announced the appointment of Matt Studney as its new Chief Customer Officer. With over 24 years of experience in the pharmaceutical and biotech industries, Studney brings a wealth of knowledge in science, data, and technology. His background includes leading digital transformation efforts at Merck, where he worked closely with scientific teams to modernize research platforms and expand AI capabilities.

Bringing Industry Expertise to Scientific Data Platforms

At Merck, Studney served as Senior Vice President of R&D IT and Key Partnerships. He spearheaded large-scale projects to upgrade laboratory and development tools, helping scientists work faster and more reliably. His efforts also supported better data reuse, cloud integration, and AI deployment—benefits that improved decision-making for thousands of researchers worldwide.

His work at Merck resulted in significant efficiencies, including a 33% reduction in discovery cycle times and regulatory submission delays cut by up to four weeks. These achievements demonstrated how strategic technology investments can accelerate pharmaceutical research and reduce costs. Studney’s experience in building partnerships with companies like AWS, NVIDIA, and Accenture further highlights his ability to drive innovation through collaboration.

The Industry’s Shift Toward Platform-Based Scientific AI

Studney’s move to TetraScience is seen as a sign of a broader change in biopharma. As scientific complexity grows and AI becomes more vital to staying competitive, companies are shifting away from custom, project-specific solutions. Instead, they are adopting shared platforms designed to make scientific data more scalable, reliable, and reusable across organizations.

Patrick Grady, TetraScience’s CEO and co-founder, emphasizes that Matt’s experience with traditional approaches shows the need for a new architectural foundation. Grady believes that platform-based solutions are key to making scientific intelligence durable and cumulative, enabling faster innovation and better collaboration across teams.

Studney himself notes that true transformation in pharma now requires a fundamental change in infrastructure. Fragmented data and workflows no longer support the pace of modern data-driven research. TetraScience’s platform aims to provide the building blocks for industrializing scientific data and making learning continuous and scalable across entire organizations.

Throughout his career, Studney has built strong relationships within the industry and understands the challenges of scaling scientific insights. His expertise will help TetraScience strengthen its position as a leader in scientific data platforms and AI solutions. His appointment reflects a commitment to helping pharmaceutical companies unlock the full potential of their data and AI capabilities for faster, more reliable research outcomes.

Inspired by

• https://ai-techpark.com/tetrascience-appoints-matt-studney-as-chief-customer-officer/